Showing results (11-20 of 55) with videos related to
Sort By:
Pageof 6
BMC Neurology|October 18, 2015
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapsesOla Caster, I Ralph EdwardsExpert Opinion on Drug Safety|June 16, 2006
The challenge of effectively communicating patient safety informationBruce Hugman, I Ralph EdwardsDrug Safety|December 23, 2015
Pharmacovigilance is... VigilanceI Ralph Edwards, Rachida Soulayamani BencheikhDrug Safety|May 8, 2019
Pharmacovigilance as Scientific Discovery: An Argument for Trans-DisciplinarityElena Rocca, Samantha Copeland, I Ralph EdwardsDrug Safety|June 1, 2007
Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibaseI Ralph Edwards, Kristina Star, Anne KiuruPlos One|October 11, 2014
Valproic acid and fatalities in children: a review of individual case safety reports in VigiBaseKristina Star, I Ralph Edwards, Imti ChoonaraDrug Safety|November 28, 2002
Labelling and 'Dear Doctor' letters: are they noncommittal?A C Kees van Grootheest, I Ralph EdwardsTheoretical Biology & Medical Modelling|March 26, 2014
Computing limits on medicine risks based on collections of individual case reportsOla Caster, G Niklas Norén, I Ralph EdwardsBritish Journal of Clinical Pharmacology|September 11, 2009
Rhabdomyolysis a result of azithromycin and statins: an unrecognized interactionJohanna Strandell, Andrew Bate, Staffan Hägg, et al.Pageof 6